Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
- Authors
- R. MollA D LoweWerner W. Franke
- Journal
- PubMed
In The Last Decade
doi.org/w59071484 →Countries where authors are citing Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
This map shows the geographic impact of Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. more than expected).
Fields of papers citing Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
This network shows the impact of Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies..
About Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
This paper, published in 1992, received 659 indexed citations . Written by R. Moll, A D Lowe and Werner W. Franke covering the research area of Oncology, Epidemiology and Pathology and Forensic Medicine. It is primarily cited by scholars working on Oncology (304 citations), Surgery (203 citations) and Cell Biology (142 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w59071484.